RNA-binding proteins regulating the CD44 alternative splicing
Alternative splicing is often deregulated in cancer, and cancer-specific isoform switches are part of the oncogenic transformation of cells. Accumulating evidence indicates that isoforms of the multifunctional cell-surface glycoprotein CD44 play different roles in cancer cells as compared to normal...
Main Authors: | Diana Maltseva, Alexander Tonevitsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1326148/full |
Similar Items
-
Identification and Characterization of CD44RC, a Novel Alternatively Spliced Soluble CD44 Isoform that can Potentiate the Hyaluronan Binding Activity of Cell Surface CD44
by: Roland K. Chiu, et al.
Published: (1999-11-01) -
Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer
by: Tong Xu, et al.
Published: (2022-11-01) -
Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer
by: Le Chen, et al.
Published: (2017-10-01) -
Spontaneous metastasis xenograft models link CD44 isoform 4 to angiogenesis, hypoxia, EMT and mitochondria‐related pathways in colorectal cancer
by: Arun Everest‐Dass, et al.
Published: (2024-01-01) -
Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer
by: Kenji Tsuchihashi, et al.
Published: (2022-07-01)